v3.26.1
Cover - shares
 3 Months Ended
Mar. 31, 2025
May 21, 2025
Cover [Abstract]    
Entity Registrant Name GOLDENWELL BIOTECH, INC.  
Entity Central Index Key 0001800373  
Document Type 10-Q/A  
Amendment Flag true  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Mar. 31, 2025  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   99,000,000
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-56275  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 84-2896086  
Entity Address Address Line 1 581 Boston Mills Road  
Entity Address Address Line 2 Suite 300  
Entity Address City Or Town Hudson  
Entity Address State Or Province OH  
Entity Address Postal Zip Code 44087  
City Area Code 440  
Local Phone Number 666-7999  
Entity Interactive Data Current Yes  
Amendment Description On May 27, 2026, Goldenwell Biotech, Inc. (the “Company”), filed a Current Report on Form 8-K, disclosing, among other things, that the financial statements disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the “March 31, 2025 Form 10-Q”), filed with the Securities and Exchange Commission (the “SEC”) on May 27, 2025, could no longer be relied upon. This Amendment No. 1 to Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, fully restates the Company’s financial statements for the fiscal quarter ended March 31, 2025, and its related notes to financial statements and related disclosures in Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations).